Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis

Clinical Microbiology Reviews

Volumn 23, Issue 3, 2010, Pages 467-492

  Brouwer, Matthijs C ^a   Tunkel, Allan R ^b   Van De Beek, Diederik ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MONMOUTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CELL PROTEIN; CEPHALOSPORIN; GENTAMICIN; MEROPENEM; PNEUMOCOCCUS VACCINE; PROTEIN STREM 1; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL VACCINE;

BACTERIAL MENINGITIS; BLOOD CULTURE; CELL COUNT; CELL CULTURE; CEREBROSPINAL FLUID ANALYSIS; DISEASE CONTROL; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM STAINING; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE TYPE A; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LABORATORY TEST; LATEX AGGLUTINATION TEST; LISTERIA MONOCYTOGENES; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVIEW; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SUIS; VACCINATION; BACTERIA; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MENINGITIS, BACTERIAL; MICROBIOLOGICAL EXAMINATION; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL VACCINES; BACTERIOLOGICAL TECHNIQUES; CROSS INFECTION; HUMANS; IMMUNOCOMPROMISED HOST; MENINGITIS, BACTERIAL;

EID: 77954618806     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00070-09     Document Type: Review

References (357)

1. Abraham, E., P. F. Laterre, R. Garg, H. Levy, D. Talwar, B. L. Trzaskoma, B. Francois, J. S. Guy, M. Bruckmann, A. Rea-Neto, R. Rossaint, D. Perrotin, A. Sablotzki, N. Arkins, B. G. Utterback, and W. L. Macias. 2005. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med. 353:1332-1341.
2. Adams, W. G., K. A. Deaver, S. L. Cochi, B. D. Plikaytis, E. R. Zell, C. V. Broome, and J. D. Wenger. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269:221-226.
3. Adegbola, R. A., O. Secka, G. Lahai, N. Lloyd-Evans, A. Njie, S. Usen, C. Oluwalana, S. Obaro, M. Weber, T. Corrah, K. Mulholland, K. McAdam, B. Greenwood, and P. J. Milligan. 2005. Elimination of Haemophilus in- fluenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366:144-150.
4. Adriani, K. S., D. van de Beek, M. C. Brouwer, L. Spanjaard, and J. de Gans. 2007. Community-acquired recurrent bacterial meningitis in adults. Clin. Infect. Dis. 45:e46-e51.
5. Allen, U. D., L. Navas, and S. M. King. 1993. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. CMAJ 149:1659-1665.
6. Andersen, J., R. Christensen, and J. Hertel. 2004. Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001. Acta Paediatr. 93:1334-1339. (Pubitemid 39273906)
7. Anh, D. D., P. E. Kilgore, W. A. Kennedy, B. Nyambat, H. T. Long, L. Jodar, J. D. Clemens, and J. I. Ward. 2006. Haemophilus influenzae type B meningitis among children in Hanoi, Vietnam: epidemiologic patterns and estimates of H. influenzae type B disease burden. Am. J. Trop. Med. Hyg. 74:509-515.
8. Aouaj, Y., L. Spanjaard, N. van Leeuwen, and J. Dankert. 2002. Listeria monocytogenes meningitis: serotype distribution and patient characteristics in the Netherlands, 1976-95. Epidemiol. Infect. 128:405-409.
9. Arda, B., O. R. Sipahi, S. Atalay, and S. Ulusoy. 2008. Pooled analysis of 2,408 cases of acute adult purulent meningitis from Turkey. Med. Princ. Pract. 17:76-79.
10. Ardanuy, C., F. Tubau, R. Pallares, L. Calatayud, M. A. Dominguez, D. Rolo, I. Grau, R. Martin, and J. Linares. 2009. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin. Infect. Dis. 48:57-64.
11. Arditi, M., E. O. Mason, Jr., J. S. Bradley, T. Q. Tan, W. J. Barson, G. E. Schutze, E. R. Wald, L. B. Givner, K. S. Kim, R. Yogev, and S. L. Kaplan. 1998. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102:1087-1097.
12. Arend, S. M., A. P. Lavrijsen, I. Kuijken, R. N. van der Plas, and E. J. Kuijper. 2006. Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease. Eur. J. Clin. Microbiol. Infect. Dis. 25:643-649.
13. Arifeen, S. E., S. K. Saha, S. Rahman, K. M. Rahman, S. M. Rahman, S. Bari, A. Naheed, I. Mannan, M. H. Seraji, N. U. Ahmed, M. S. Hassan, N. Huda, A. U. Siddik, I. Quasem, M. Islam, K. Fatima, H. Al-Emran, W. A. Brooks, A. H. Baqui, R. F. Breiman, D. Sack, and S. P. Luby. 2009. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin. Infect. Dis. 48(Suppl. 2):S103-S113.
14. Arnoni, M. V., E. N. Berezin, M. A. Safadi, F. J. Almeida, and C. R. Lopes. 2007. Streptococcus pyogenes meningitis in children: report of two cases and literature review. Braz. J. Infect. Dis. 11:375-377.
15. Auburtin, M., R. Porcher, F. Bruneel, A. Scanvic, J. L. Trouillet, J. P. Bedos, B. Regnier, and M. Wolff. 2002. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am. J. Respir. Crit. Care Med. 165:713-717.
16. Backman, A., P. Lantz, P. Radstrom, and P. Olcen. 1999. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples. Mol. Cell. Probes 13:49-60.
17. Baggett, H. C., L. F. Peruski, S. J. Olsen, S. Thamthitiwat, J. Rhodes, S. Dejsirilert, W. Wongjindanon, S. F. Dowell, J. E. Fischer, P. Areerat, D. Sornkij, P. Jorakate, A. Kaewpan, P. Prapasiri, S. Naorat, L. Sangsuk, B. Eampokalap, M. R. Moore, G. Carvalho, B. Beall, K. Ungchusak, and S. A. Maloney. 2009. Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand. Clin. Infect. Dis. 48(Suppl. 2) :S65-S74.
18. Baltas, I., S. Tsoulfa, P. Sakellariou, V. Vogas, M. Fylaktakis, and A. Kondodimou. 1994. Posttraumatic meningitis: bacteriology, hydrocephalus, and outcome. Neurosurgery 35:422-426.
19. Baraff, L. J., S. I. Lee, and D. L. Schriger. 1993. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr. Infect. Dis. J. 12:389-394.
20. Baraldes, M. A., P. Domingo, A. Mauri, J. Monmany, M. Castellanos, R. Pericas, and G. Vazquez. 1999. Group A streptococcal meningitis in the antibiotic era. Eur. J. Clin. Microbiol. Infect. Dis. 18:572-578.
21. Bartt, R. 2000. Listeria and atypical presentations of Listeria in the central nervous system. Semin. Neurol. 20:361-373.
22. Batuwanthudawe, R., K. Karunarathne, M. Dassanayake, S. de Silva, M. K. Lalitha, K. Thomas, M. Steinhoff, and N. Abeysinghe. 2009. Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin. Infect. Dis. 48(Suppl. 2):S136-S140.
23. Beer, R., P. Lackner, B. Pfausler, and E. Schmutzhard. 2008. Nosocomial ventriculitis and meningitis in neurocritical care patients. J. Neurol. 255: 1617-1624.
24. Behrman, R. E., B. R. Meyers, M. H. Mendelson, H. S. Sacks, and S. Z. Hirschman. 1989. Central nervous system infections in the elderly. Arch. Intern. Med. 149:1596-1599.
25. Bennion, J. R., F. Sorvillo, M. E. Wise, S. Krishna, and L. Mascola. 2008. Decreasing listeriosis mortality in the United States, 1990-2005. Clin. Infect. Dis. 47:867-874.
26. Berg, S., B. Trollfors, B. A. Claesson, K. Alestig, L. Gothefors, S. Hugosson, L. Lindquist, P. Olcen, V. Romanus, and K. Strangert. 1996. Incidence and prognosis of meningitis due to Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis in Sweden. Scand. J. Infect. Dis. 28:247-252.
27. Bernard, G. R., J. L. Vincent, P. F. Laterre, S. P. LaRosa, J. F. Dhainaut, A. Lopez-Rodriguez, J. S. Steingrub, G. E. Garber, J. D. Helterbrand, E. W. Ely, and C. J. Fisher, Jr. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
28. Biernath, K. R., J. Reefhuis, C. G. Whitney, E. A. Mann, P. Costa, J. Eichwald, and C. Boyle. 2006. Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics 117:284-289.
29. Bilukha, O. O., and N. Rosenstein. 2005. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 54(RR7): 1-21.
30. Bingen, E., N. Lambert-Zechovsky, E. Guihaire, C. Mancy, Y. Aujard, and H. Mathieu. 1986. Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci. Pathol. Biol. (Paris) 34:530-533. (In French.)
31. Bingen, E., C. Levy, F. de la Rocque, M. Boucherat, E. Varon, J. M. Alonso, H. Dabernat, P. Reinert, Y. Aujard, and R. Cohen. 2005. Bacterial meningitis in children: a French prospective study. Clin. Infect. Dis. 41:1059-1063.
32. Bishara, J., N. Hadari, M. Shalita-Chesner, Z. Samra, O. Ofir, M. Paul, N. Peled, S. Pitlik, and Y. Molad. 2007. Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur. J. Clin. Microbiol. Infect. Dis. 26:647-650.
33. Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. R. Hansen, L. Elvin, K. M. Ensor, J. Hackell, G. Siber, F. Malinoski, D. Madore, I. Chang, R. Kohberger, W. Watson, R. Austrian, and K. Edwards. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19:187-195.
34. Bliss, S. J., K. L. O'Brien, E. N. Janoff, M. F. Cotton, P. Musoke, H. Coovadia, and O. S. Levine. 2008. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect. Dis. 8:67-80.
35. Bohr, V., N. Rasmussen, B. Hansen, H. Kjersem, O. Jessen, N. Johnsen, and H. S. Kristensen. 1983. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. J. Infect. 7:193-202.
36. Boisier, P., P. Nicolas, S. Djibo, M. K. Taha, I. Jeanne, H. B. Mainassara, B. Tenebray, K. K. Kairo, D. Giorgini, and S. Chanteau. 2007. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin. Infect. Dis. 44:657-663.
37. Bolan, G., C. V. Broome, R. R. Facklam, B. D. Plikaytis, D. W. Fraser, and W. F. Schlech III. 1986. Pneumococcal vaccine efficacy in selected populations in the United States. Ann. Intern. Med. 104:1-6.
38. Bonsu, B. K., and M. B. Harper. 2004. Differentiating acute bacterial meningitis from acute viral meningitis among children with cerebrospinal fluid pleocytosis: a multivariable regression model. Pediatr. Infect. Dis. J. 23:511-517.
39. Bonsu, B. K., H. W. Ortega, M. J. Marcon, and M. B. Harper. 2008. A decision rule for predicting bacterial meningitis in children with cerebrospinal fluid pleocytosis when Gram stain is negative or unavailable. Acad. Emerg. Med. 15:437-444.
40. Bose, A., P. Coen, J. Tully, R. Viner, and R. Booy. 2003. Effectiveness of meningococcal C conjugate vaccine in teenagers in England. Lancet 361: 675-676.
41. Boving, M. K., L. N. Pedersen, and J. K. Moller. 2009. Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. J. Clin. Microbiol. 47:908-913.
42. Boyer, D., R. C. Gordon, and T. Baker. 1993. Lack of clinical usefulness of a positive latex agglutination test for Neisseria meningitidis/Escherichia coli antigens in the urine. Pediatr. Infect. Dis. J. 12:779-780.
43. Bronska, E., J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, and J. Benes. 2006. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin. Microbiol. Infect. 12:137-141.
44. Brouwer, M. C., J. de Gans, S. G. Heckenberg, A. H. Zwinderman, T. van der Poll, and D. van de Beek. 2009. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 9:31-44.
45. Brouwer, M. C., G. D. Keizerweerd, J. de Gans, L. Spanjaard, and D. van de Beek. 2009. Community acquired Staphylococcus aureus meningitis in adults. Scand. J. Infect. Dis. 41:375-377.
46. Brouwer, M. C., and D. van de Beek. 2009. Genetics in meningococcal disease: one step beyond. Clin. Infect. Dis. 48:595-597.
47. Brouwer, M. C., D. van de Beek, S. G. Heckenberg, L. Spanjaard, and J. de Gans. 2006. Community-acquired Listeria monocytogenes meningitis in adults. Clin. Infect. Dis. 43:1233-1238.
48. Brouwer, M. C., D. van de Beek, S. G. Heckenberg, L. Spanjaard, and J. de Gans. 2007. Community-acquired Haemophilus influenzae meningitis in adults. Clin. Microbiol. Infect. 13:439-442.
49. Bruyn, G. A., H. P. Kremer, S. de Marie, G. W. Padberg, J. Hermans, and R. van Furth. 1989. Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur. J. Clin. Microbiol. Infect. Dis. 8:695-700.
50. Bryan, J. P., H. R. de Silva, A. Tavares, H. Rocha, and W. M. Scheld. 1990. Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev. Infect. Dis. 12:128-135.
51. Bula, C. J., J. Bille, and M. P. Glauser. 1995. An epidemic of food-borne listeriosis in western Switzerland: description of 57 cases involving adults. Clin. Infect. Dis. 20:66-72.
52. Butler, J. C., R. F. Breiman, J. F. Campbell, H. B. Lipman, C. V. Broome, and R. R. Facklam. 1993. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 270:1826-1831.
53. Cabellos, C., R. Verdaguer, M. Olmo, N. Fernandez-Sabe, M. Cisnal, J. Ariza, F. Gudiol, and P. F. Viladrich. 2009. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore) 88:115-119.
54. Campagne, G., A. Schuchat, S. Djibo, A. Ousseini, L. Cisse, and J. P. Chippaux. 1999. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull. World Health Organ. 77:499-508.
55. Carpenter, R. R., and R. G. Petersdorf. 1962. The clinical spectrum of bacterial meningitis. Am. J. Med. 33:262-275.
56. Carrol, E. D., M. Guiver, S. Nkhoma, L. A. Mankhambo, J. Marsh, P. Balmer, D. L. Banda, G. Jeffers, S. A. White, E. M. Molyneux, M. E. Molyneux, R. L. Smyth, and C. A. Hart. 2007. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr. Infect. Dis. J. 26:416-422.
57. Casado-Flores, J., J. Aristegui, C. R. de Liria, J. M. Martinon, and C. Fernandez. 2006. Clinical data and factors associated with poor outcome in pneumococcal meningitis. Eur. J. Pediatr. 165:285-289.
58. Casado-Flores, J., B. Osona, P. Domingo, and N. Barquet. 1997. Meningococcal meningitis during penicillin therapy for meningococcemia. Clin. Infect. Dis. 25:1479.
59. Casado-Flores, J., C. Rodrigo, J. Aristegui, J. M. Martinon, A. Fenoll, and C. Mendez. 2008. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 27:1020-1022.
60. Reference deleted.
61. Centers for Disease Control and Prevention. 2007. Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR Morb. Mortal. Wkly. Rep. 56:794-795.
62. Centers for Disease Control and Prevention. 2008. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005. MMWR Morb. Mortal. Wkly. Rep. 57:144-148.
63. Centers for Disease Control and Prevention. 2008. Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. MMWR Morb. Mortal. Wkly. Rep. 57:1148-1151.
64. Centers for Disease Control and Prevention. 2009. Active bacterial core surveillance. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/abcs/survreports/mening08.pdf.
65. Centers for Disease Control and Prevention. 2009. Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR Morb. Mortal. Wkly. Rep. 58:109-112.
66. Centers for Disease Control and Prevention. 2009. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb. Mortal. Wkly. Rep. 58:1042-1043.
67. Chang, W. N., C. H. Lu, J. J. Wu, H. W. Chang, Y. C. Tsai, F. T. Chen, and C. C. Chien. 2001. Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillinsensitive strains. Infection 29:245-250.
68. Chao, Y. N., N. C. Chiu, and F. Y. Huang. 2008. Clinical features and prognostic factors in childhood pneumococcal meningitis. J. Microbiol. Immunol. Infect. 41:48-53.
69. Chaudhuri, A., P. Martinez-Martin, P. G. Kennedy, S. R. Andrew, P. Portegies, M. Bojar, and I. Steiner. 2008. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur. J. Neurol. 15:649-659.
70. Chen, H. P., C. H. Lai, Y. J. Chan, T. L. Chen, C. Y. Liu, C. P. Fung, and C. Y. Liu. 2005. Clinical significance of Acinetobacter species isolated from cerebrospinal fluid. Scand. J. Infect. Dis. 37:669-675.
71. Chiba, N., S. Y. Murayama, M. Morozumi, E. Nakayama, T. Okada, S. Iwata, K. Sunakawa, and K. Ubukata. 2009. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. J. Infect. Chemother. 15:92-98.
72. Choi, C. 2001. Bacterial meningitis in aging adults. Clin. Infect. Dis. 33: 1380-1385.
73. Clarke, S. C., J. Reid, L. Thom, and G. F. Edwards. 2001. Confirmation of meningococcal disease by urinary antigen testing. Clin. Microbiol. Infect. 7:565-567.
74. Clauss, H. E., and B. Lorber. 2008. Central nervous system infection with Listeria monocytogenes. Curr. Infect. Dis. Rep. 10:300-306.
75. Colodner, R., W. Sakran, D. Miron, N. Teitler, E. Khavalevsky, and J. Kopelowitz. 2003. Listeria monocytogenes cross-contamination in a nursery. Am. J. Infect. Control 31:322-324.
76. Conen, A., L. N. Walti, A. Merlo, U. Fluckiger, M. Battegay, and A. Trampuz. 2008. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin. Infect. Dis. 47:73-82.
77. Corless, C. E., M. Guiver, R. Borrow, V. Edwards-Jones, A. J. Fox, and E. B. Kaczmarski. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J. Clin. Microbiol. 39:1553-1558.
78. Cowgill, K. D., M. Ndiritu, J. Nyiro, M. P. Slack, S. Chiphatsi, A. Ismail, T. Kamau, I. Mwangi, M. English, C. R. Newton, D. R. Feikin, and J. A. Scott. 2006. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 296: 671-678.
79. Crouzet-Ozenda, L., H. Haas, E. Bingen, A. Lecuyer, C. Levy, and R. Cohen. 2008. Listeria monocytogenes meningitis in children in France. Arch. Pediatr. 15(Suppl. 3):S158-S160. (In French.)
80. Dagan, R., and K. P. Klugman. 2008. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect. Dis. 8:785-795.
81. Daoud, A. S., A. Batieha, M. Al-Sheyyab, F. Abuekteish, A. Obeidat, and T. Mahafza. 1999. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur. J. Pediatr. 158:230-233.
82. Darton, T., M. Guiver, S. Naylor, D. L. Jack, E. B. Kaczmarski, R. Borrow, and R. C. Read. 2009. Severity of meningococcal disease associated with genomic bacterial load. Clin. Infect. Dis. 48:587-594.
83. Daza, P., R. Banda, K. Misoya, A. Katsulukuta, B. D. Gessner, R. Katsande, B. R. Mhlanga, J. E. Mueller, C. B. Nelson, A. Phiri, E. M. Molyneux, and M. E. Molyneux. 2006. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 24: 6232-6239.
84. De Cauwer, H. G., L. Eykens, J. Hellinckx, and L. J. Mortelmans. 2007. Differential diagnosis between viral and bacterial meningitis in children. Eur. J. Emerg. Med. 14:343-347.
85. Decosas, J., and J. B. Koama. 2002. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect. Dis. 2:763-765.
86. de Gans, J., and D. van de Beek. 2002. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347:1549-1556.
87. Derkx, B., J. Wittes, and R. McCloskey. 1999. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin. Infect. Dis. 28:770-777.
88. Dery, M., and R. Hasbun. 2007. Changing epidemiology of bacterial meningitis. Curr. Infect. Dis. Rep. 9:301-307.
89. Determann, R. M., M. Weisfelt, J. de Gans, A. van der Ende, M. J. Schultz, and D. van de Beek. 2006. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med. 32:1243-1247. (Pubitemid 44232421)
90. Domingo, P., N. Barquet, M. Alvarez, P. Coll, J. Nava, and J. Garau. 1997. Group B streptococcal meningitis in adults: report of twelve cases and review. Clin. Infect. Dis. 25:1180-1187.
91. Domingo, P., R. Pericas, B. Mirelis, J. Nolla, and G. Prats. 1998. Haemophilus influenzae meningitis in adults: analysis of 12 cases. Med. Clin. (Barc.) 111:294-297. (In Spanish.)
92. Drummond, D. S., A. L. de Jong, C. Giannoni, M. Sulek, and E. M. Friedman. 1999. Recurrent meningitis in the pediatric patient-the otolaryngologist's role. Int. J. Pediatr. Otorhinolaryngol. 48:199-208.
93. Dubos, F., B. Korczowski, D. A. Aygun, A. Martinot, C. Prat, A. Galetto- Lacour, J. Casado-Flores, E. Taskin, F. Leclerc, C. Rodrigo, A. Gervaix, S. Leroy, D. Gendrel, G. Breart, and M. Chalumeau. 2008. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch. Pediatr. Adolesc. Med. 162:1157-1163.
94. Dunne, D. W., and V. Quagliarello. 1993. Group B streptococcal meningitis in adults. Medicine (Baltimore) 72:1-10.
95. Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med. 328:21-28.
96. Dworkin, M. S., L. Park, and S. M. Borchardt. 2007. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin. Infect. Dis. 44:810-816.
97. El Bashir, H., M. Laundy, and R. Booy. 2003. Diagnosis and treatment of bacterial meningitis. Arch. Dis. Child. 88:615-620.
98. Falade, A. G., I. A. Lagunju, R. A. Bakare, A. A. Odekanmi, and R. A. Adegbola. 2009. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria. Clin. Infect. Dis. 48(Suppl. 2):S190-S196.
99. Farhoudi, D., M. Lofdahl, and J. Giesecke. 2005. Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era. Scand. J. Infect. Dis. 37:717-722.
100. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N. Engl. J. Med. 328:1807-1811.
101. Farley, M. M., D. S. Stephens, P. S. Brachman, Jr., R. C. Harvey, J. D. Smith, and J. D. Wenger. 1992. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann. Intern. Med. 116:806-812.
102. Federico, G., M. Tumbarello, T. Spanu, R. Rosell, M. Iacoangeli, M. Scerrati, and E. Tacconelli. 2001. Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. Scand. J. Infect. Dis. 33:533-537.
103. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42:1517-1519.
104. Figueroa, J. E., and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359-395.
105. Fijen, C. A., E. J. Kuijper, H. G. Tjia, M. R. Daha, and J. Dankert. 1994. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin. Infect. Dis. 18:780-784.
106. Fitch, M. T., and D. van de Beek. 2007. Emergency diagnosis and treatment of adult meningitis. Lancet Infect. Dis. 7:191-200.
107. Flatz, L., M. Cottagnoud, F. Kuhn, J. Entenza, A. Stucki, and P. Cottagnoud. 2004. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. J. Antimicrob. Chemother. 53:305-310.
108. Fleming, D. W., S. L. Cochi, K. L. MacDonald, J. Brondum, P. S. Hayes, B. D. Plikaytis, M. B. Holmes, A. Audurier, C. V. Broome, and A. L. Reingold. 1985. Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N. Engl. J. Med. 312:404-407.
109. Fong, I. W., and P. Ranalli. 1984. Staphylococcus aureus meningitis. Q. J. Med. 53:289-299.
110. Franco-Paredes, C., L. Lammoglia, I. Hernandez, and J. I. Santos-Preciado. 2008. Epidemiology and outcomes of bacterial meningitis in Mexican children: 10-year experience (1993-2003). Int. J. Infect. Dis. 12:380-386.
111. Frankel, R. E., M. Virata, C. Hardalo, F. L. Altice, and G. Friedland. 1996. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin. Infect. Dis. 23: 577-584.
112. Gales, A. C., R. N. Jones, and H. S. Sader. 2006. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin. Microbiol. Infect. 12:315-321.
113. Galiza, E. P., and P. T. Heath. 2009. Improving the outcome of neonatal meningitis. Curr. Opin. Infect. Dis. 22:229-234.
114. Garcia, V. E., J. Mensa, J. A. Martinez, M. A. Marcos, J. Puig, M. Ortega, and A. Torres. 2005. Lower mortality among patients with communityacquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. Eur. J. Clin. Microbiol. Infect. Dis. 24: 190-195.
115. Gardner, P. 2006. Clinical practice. Prevention of meningococcal disease. N. Engl. J. Med. 355:1466-1473.
116. Garges, H. P., M. A. Moody, C. M. Cotten, P. B. Smith, K. F. Tiffany, R. Lenfestey, J. S. Li, V. G. Fowler, Jr., and D. K. Benjamin, Jr. 2006. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics 117:1094-1100.
117. Garner, D., and V. Weston. 2003. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 361:395-396.
118. Garpenholt, O., S. A. Silfverdal, S. Hugosson, H. Fredlund, L. Bodin, V. Romanus, and P. Olcen. 1996. The impact of Haemophilus influenzae type b vaccination in Sweden. Scand. J. Infect. Dis. 28:165-169.
119. Gavi Alliance. 2009. The Gambia introduces vaccine against world's leading vaccine-preventable child killer. Gavi Alliance, Geneva, Switzerland. http://www.gavialliance.org/media-centre/press-releases/2009-08-19-gambia -pneumococcal.php.
120. Geiseler, P. J., K. E. Nelson, S. Levin, K. T. Reddi, and V. K. Moses. 1980. Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976. Rev. Infect. Dis. 2:725-745.
121. Georget-Bouquinet, E., E. Bingen, Y. Aujard, C. Levy, and R. Cohen. 2008. Group B streptococcal meningitis' clinical, biological and evolutive features in children. Arch. Pediatr. 15(Suppl. 3):S126-S132. (In French.)
122. Gessner, B. D., A. Sutanto, M. Linehan, I. G. Djelantik, T. Fletcher, I. K. Gerudug, Ingerani, D. Mercer, V. Moniaga, L. H. Moulton, K. Mulholland, C. Nelson, S. Soemohardjo, M. Steinhoff, A. Widjaya, P. Stoeckel, J. Maynard, and S. Arjoso. 2005. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 365:43-52.
123. Giamarellou, H., and G. Poulakou. 2009. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69:1879-1901.
124. Ginsberg, L. 2004. Difficult and recurrent meningitis. J. Neurol. Neurosurg. Psychiatry 75(Suppl. 1):i16-i21.
125. Giorgi Rossi, P., J. Mantovani, E. Ferroni, A. Forcina, E. Stanghellini, F. Curtale, and P. Borgia. 2009. Incidence of bacterial meningitis (2001-2005) in Lazio, Italy: the results of a integrated surveillance system. BMC Infect. Dis. 9:13.
126. Giovanetti, E., M. P. Montanari, M. Mingoia, and P. E. Varaldo. 1999. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 43:1935-1940.
127. Goldani, L. Z. 1998. Inducement of Neisseria meningitidis resistance to ampicillin and penicillin in a patient with meningococcemia treated with high doses of ampicillin. Clin. Infect. Dis. 26:772.
128. Gordon, S. B., M. Chaponda, A. L. Walsh, C. J. Whitty, M. A. Gordon, C. E. Machili, C. F. Gilks, M. J. Boeree, S. Kampondeni, R. C. Read, and M. E. Molyneux. 2002. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS 16:1409-1417.
129. Gordon, S. B., A. L. Walsh, M. Chaponda, M. A. Gordon, D. Soko, M. Mbwvinji, M. E. Molyneux, and R. C. Read. 2000. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin. Infect. Dis. 31:53-57.
130. Grau, I., R. Pallares, F. Tubau, M. H. Schulze, F. Llopis, D. Podzamczer, J. Linares, and F. Gudiol. 2005. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch. Intern. Med. 165:1533-1540.
131. Gray, L. D., and D. P. Fedorko. 1992. Laboratory diagnosis of bacterial meningitis. Clin. Microbiol. Rev. 5:130-145.
132. Gray, S. J., C. L. Trotter, M. E. Ramsay, M. Guiver, A. J. Fox, R. Borrow, R. H. Mallard, and E. B. Kaczmarski. 2006. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J. Med. Microbiol. 55: 887-896.
133. Greenberg, D. 2009. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines. Clin. Infect. Dis. 49:213-215.
134. Greenwood, B. M. 1987. The epidemiology of acute bacterial meningitis in tropical Africa, p. 93-113. In J. D. Williams and J. Burnie (ed.), Bacterial meningitis. Academic Press, London, United Kingdom.
135. Hackett, S. J., E. D. Carrol, M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002. Improved case confirmation in meningococcal disease with whole blood Taqman PCR. Arch. Dis. Child. 86:449-452.
136. Harrison, C. J., C. Woods, G. Stout, B. Martin, and R. Selvarangan. 2009. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J. Antimicrob. Chemother. 63:511-519.
137. Hasegawa, K., R. Kobayashi, E. Takada, A. Ono, N. Chiba, M. Morozumi, S. Iwata, K. Sunakawa, and K. Ubukata. 2006. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J. Antimicrob. Chemother. 57:1077-1082. doi:10.1093/jac/ dkl142.
138. Hayden, R. T., and L. D. Frenkel. 2000. More laboratory testing: greater cost but not necessarily better. Pediatr. Infect. Dis. J. 19:290-292.
139. Heath, P. T., G. Balfour, A. M. Weisner, A. Efstratiou, T. L. Lamagni, H. Tighe, L. A. O'Connell, M. Cafferkey, N. Q. Verlander, A. Nicoll, and A. C. McCartney. 2004. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363:292-294.
140. Heath, P. T., N. K. N. Yusoff, and C. J. Baker. 2003. Neonatal meningitis. Arch. Dis. Child. Fetal Neonatal Ed. 88:F173-F178.
141. Heckenberg, S. G., J. de Gans, M. C. Brouwer, M. Weisfelt, J. R. Piet, L. Spanjaard, A. van der Ende, and D. van de Beek. 2008. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 87:185-192.
142. Hedberg, S. T., P. Olcen, H. Fredlund, and P. Molling. 2009. Real-time PCR detection of five prevalent bacteria causing acute meningitis. APMIS 117:856-860.
143. Heffernan, R. T., N. L. Barrett, K. M. Gallagher, J. L. Hadler, L. H. Harrison, A. L. Reingold, K. Khoshnood, T. R. Holford, and A. Schuchat. 2005. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J. Infect. Dis. 191:2038-2045.
144. Heyderman, R. S., H. P. Lambert, I. O'Sullivan, J. M. Stuart, B. L. Taylor, and R. A. Wall. 2003. Early management of suspected bacterial meningitis and meningococcal septicaemia in adults. J. Infect. 46:75-77.
145. Reference deleted.
146. Hicks, L. A., L. H. Harrison, B. Flannery, J. L. Hadler, W. Schaffner, A. S. Craig, D. Jackson, A. Thomas, B. Beall, R. Lynfield, A. Reingold, M. M. Farley, and C. G. Whitney. 2007. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354.
147. Higa, T., T. Tasaka, Y. Kubo, I. Nakagiri, F. Sano, Y. Matsuhashi, Y. Fukai, H. Wada, K. Tohyama, and T. Sugihara. 2008. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient. Scand. J. Infect. Dis. 40:990-992.
148. Hoen, B., J. F. Viel, A. Gerard, J. B. Dureux, and P. Canton. 1993. Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors. Eur. J. Med. 2:28-32.
149. Hoen, B., J. F. Viel, C. Paquot, A. Gerard, and P. Canton. 1995. Multivariate approach to differential diagnosis of acute meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 14:267-274.
150. Holden, M. T., H. Hauser, M. Sanders, T. H. Ngo, I. Cherevach, A. Cronin, I. Goodhead, K. Mungall, M. A. Quail, C. Price, E. Rabbinowitsch, S. Sharp, N. J. Croucher, T. B. Chieu, N. T. Mai, T. S. Diep, N. T. Chinh, M. Kehoe, J. A. Leigh, P. N. Ward, C. G. Dowson, A. M. Whatmore, N. Chanter, P. Iversen, M. Gottschalk, J. D. Slater, H. E. Smith, B. G. Spratt, J. Xu, C. Ye, S. Bentley, B. G. Barrell, C. Schultsz, D. J. Maskell, and J. Parkhill. 2009. Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One 4:e6072.
151. Hoogman, M., D. van de Beek, M. Weisfelt, J. de Gans, and B. Schmand. 2007. Cognitive outcome in adults after bacterial meningitis. J. Neurol. Neurosurg. Psychiatry 78:1092-1096.
152. Hristeva, L., R. Booy, I. Bowler, and A. R. Wilkinson. 1993. Prospective surveillance of neonatal meningitis. Arch. Dis. Child. 69:14-18.
153. Hsu, H. E., K. A. Shutt, M. R. Moore, B. W. Beall, N. M. Bennett, A. S. Craig, M. M. Farley, J. H. Jorgensen, C. A. Lexau, S. Petit, A. Reingold, W. Schaffner, A. Thomas, C. G. Whitney, and L. H. Harrison. 2009. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 360:244-256.
154. Iannini, P. B., and M. J. Kunkel. 1982. Cefotaxime failure in group A streptococcal meningitis. JAMA 248:1878.
155. Ikonomidis, A., E. Neou, V. Gogou, G. Vrioni, A. Tsakris, and S. Pournaras. 2009. Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J. Clin. Microbiol. 47:4055-4059. doi:10.1128/ JCM.00959-09.
156. Iriso, R., R. Ocakacon, J. A. Acayo, M. A. Mawanda, and A. Kisayke. 2008. Bacterial meningitis following introduction of Hib conjugate vaccine in northern Uganda. Ann. Trop. Paediatr. 28:211-216.
157. Jackson, L. A., R. Baxter, K. Reisinger, A. Karsten, J. Shah, L. Bedell, and P. M. Dull. 2009. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents. Clin. Infect. Dis. 49:e1-e10.
158. Jackson, L. A., R. Hilsdon, M. M. Farley, L. H. Harrison, A. L. Reingold, B. D. Plikaytis, J. D. Wenger, and A. Schuchat. 1995. Risk factors for group B streptococcal disease in adults. Ann. Intern. Med. 123:415-420.
159. Jacobs, M. R. 2003. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr. Infect. Dis. J. 22:S109-S119.
160. Jacobs, M. R., C. E. Good, S. Bajaksouzian, and A. R. Windau. 2008. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin. Infect. Dis. 47:1388-1395.
161. Jaeger, F., J. Leroy, F. Duchene, V. Baty, S. Baillet, J. M. Estavoyer, and B. Hoen. 2000. Validation of a diagnosis model for differentiating bacterial from viral meningitis in infants and children under 3.5 years of age. Eur. J. Clin. Microbiol. Infect. Dis. 19:418-421.
162. Janoff, E. N., R. F. Breiman, C. L. Daley, and P. C. Hopewell. 1992. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann. Intern. Med. 117:314-324.
163. Jasir, A., A. Tanna, A. Noorani, A. Mirsalehian, A. Efstratiou, and C. Schalen. 2000. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J. Clin. Microbiol. 38:2103-2107.
164. Jensen, A. G., F. Espersen, P. Skinhoj, V. T. Rosdahl, and N. Frimodt- Moller. 1993. Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch. Intern. Med. 153:1902-1908.
165. Johri, A. K., L. C. Paoletti, P. Glaser, M. Dua, P. K. Sharma, G. Grandi, and R. Rappuoli. 2006. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4:932-942.
166. Jonsson, G., L. Truedsson, G. Sturfelt, V. A. Oxelius, J. H. Braconier, and A. G. Sjoholm. 2005. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 84:23-34.
167. Kachel, W., H. G. Lenard, D. Isaacs, and M. M. Liberman. 1981. Babies cross-infected with Listeria monocytogenes. Lancet 318:939-940.
168. Kamath, B. M., P. Mamula, R. N. Baldassano, and J. E. Markowitz. 2002. Listeria meningitis after treatment with infliximab. J. Pediatr. Gastroenterol. Nutr. 34:410-412.
169. Karanika, M., V. A. Vasilopoulou, A. T. Katsioulis, P. Papastergiou, M. N. Theodoridou, and C. S. Hadjichristodoulou. 2009. Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry. PLoS One 4:e6426.
170. Kellner, J. D., O. G. Vanderkooi, J. MacDonald, D. L. Church, G. J. Tyrrell, and D. W. Scheifele. 2009. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-Area Streptococcus pneumoniae Research (CASPER) study. Clin. Infect. Dis. 49:205-212.
171. Kessler, S. L., and A. S. Dajani. 1990. Listeria meningitis in infants and children. Pediatr. Infect. Dis. J. 9:61-63.
172. Kim, B. N., A. Y. Peleg, T. P. Lodise, J. Lipman, J. Li, R. Nation, and D. L. Paterson. 2009. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect. Dis. 9:245-255.
173. Kisakye, A., I. Makumbi, D. Nansera, R. Lewis, F. Braka, E. Wobudeya, D. Chaplain, E. Nalumansi, W. Mbabazi, and B. D. Gessner. 2009. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda. Clin. Infect. Dis. 48(Suppl. 2): S153-S161.
174. Kiska, D. L., M. C. Jones, M. E. Mangum, D. Orkiszewski, and P. H. Gilligan. 1995. Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J. Clin. Microbiol. 33:1141-1144.
175. Klugman, K. P., and C. Feldman. 1999. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem. Drugs 58:1-4.
176. Klugman, K. P., S. A. Madhi, and C. Feldman. 2007. HIV and pneumococcal disease. Curr. Opin. Infect. Dis. 20:11-15.
177. Korinek, A. M., T. Baugnon, J. L. Golmard, R. van Effenterre, P. Coriat, and L. Puybasset. 2008. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 62(Suppl. 2):532-539.
178. Korinek, A. M., J. L. Golmard, A. Elcheick, R. Bismuth, R. van Effenterre, P. Coriat, and L. Puybasset. 2005. Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4,578 patients. Br. J. Neurosurg. 19:155-162.
179. Kornelisse, R. F., C. M. Westerbeek, A. B. Spoor, B. van der Heijde, L. Spanjaard, H. J. Neijens, and R. de Groot. 1995. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin. Infect. Dis. 21:1390-1397.
180. Kragsbjerg, P., J. Kallman, and P. Olcen. 1994. Pneumococcal meningitis in adults. Scand. J. Infect. Dis. 26:659-666.
181. Kulkarni, A. V., J. M. Drake, and M. Lamberti-Pasculli. 2001. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J. Neurosurg. 94:195-201. (Pubitemid 32799678)
182. Ladhani, S., P. T. Heath, M. E. Ramsay, M. P. Slack, E. Kibwana, A. J. Pollard, and R. Booy. 2009. Long-term immunological follow-up of children with Haemophilus influenzae serotype b vaccine failure in the United Kingdom. Clin. Infect. Dis. 49:372-380.
183. Ladhani, S., M. P. Slack, M. Heys, J. White, and M. E. Ramsay. 2008. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch. Dis. Child. 93:665-669.
184. La Montagna, G., and G. Valentini. 2005. Listeria monocytogenes meningitis in a patient receiving etanercept for Still's disease. Clin. Exp. Rheumatol. 23:121.
185. Latorre, C., A. Gene, T. Juncosa, C. Munoz, and A. Gonzalez-Cuevas. 2000. Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, Spain. Acta Paediatr. 89: 661-665.
186. Latorre, C., V. Pineda, T. Juncosa, C. Munoz, A. Dominguez, R. Bou, D. Fontanals, I. Sanfeliu, I. Pons, N. Margall, F. Sanchez, R. Pericas, and E. Lobera. 2000. Haemophilus influenzae meningitis in Catalonia, Spain: epidemiology and bacteriologic characteristics. Clin. Microbiol. Infect. 6:279-282.
187. Lebel, M. H., B. J. Freij, G. A. Syrogiannopoulos, D. F. Chrane, M. J. Hoyt, S. M. Stewart, B. D. Kennard, K. D. Olsen, and G. H. McCracken, Jr. 1988. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N. Engl. J. Med. 319:964-971.
188. Leblebicioglu, H., S. Esen, A. Bedir, M. Gunaydin, and A. Sanic. 1996. The validity of Spanos' and Hoen's models for differential diagnosis of meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 15:252-254.
189. Lee, D. H., B. Palermo, and M. Chowdhury. 2008. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin. Infect. Dis. 47:588-590.
190. Lerche, A., N. Rasmussen, J. H. Wandall, and V. A. Bohr. 1995. Staphylococcus aureus meningitis: a review of 28 consecutive community-acquired cases. Scand. J. Infect. Dis. 27:569-573.
191. Levin, M., P. A. Quint, B. Goldstein, P. Barton, J. S. Bradley, S. D. Shemie, T. Yeh, S. S. Kim, D. P. Cafaro, P. J. Scannon, and B. P. Giroir. 2000. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356:961-967.
192. Levy, C., M. K. Taha, O. C. Weill, B. Quinet, A. Lecuyer, J. M. Alonso, R. Cohen, and E. Bingen. 2008. Characteristics of meningococcal meningitis in children in France. Arch. Pediatr. 15(Suppl. 3):S105-S110. (In French.)
193. Lieb, G., J. Krauss, H. Collmann, L. Schrod, and N. Sorensen. 1996. Recurrent bacterial meningitis. Eur. J. Pediatr. 155:26-30.
194. Linnan, M. J., L. Mascola, X. D. Lou, V. Goulet, S. May, C. Salminen, D. W. Hird, M. L. Yonekura, P. Hayes, and R. Weaver. 1988. Epidemic listeriosis associated with Mexican-style cheese. N. Engl. J. Med. 319:823-828.
195. Lorber, B. 1997. Listeriosis. Clin. Infect. Dis. 24:1-9.
196. Luaces, C. C., J. J. Garcia Garcia, M. J. Roca, and C. L. Latorre Otin. 1997. Clinical data in children with meningococcal meningitis in a Spanish hospital. Acta Paediatr. 86:26-29.
197. Lun, Z. R., Q. P. Wang, X. G. Chen, A. X. Li, and X. Q. Zhu. 2007. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect. Dis. 7:201-209.
198. Mai, N. T. H., N. T. Hoa, T. V. T. Nga, L. D. Linh, T. T. H. Chau, D. X. Sinh, N. H. Phu, L. V. Chuong, T. S. Diep, J. Campbell, H. D. Nghia, T. N. Minh, N. V. Chau, M. D. de Jong, N. T. Chinh, T. T. Hien, J. J. Farrar, and C. Schultsz. 2008. Streptococcus suis meningitis in adults in Vietnam. Clin. Infect. Dis. 46:659-667.
199. Maiden, M. C., A. B. Ibarz-Pavon, R. Urwin, S. J. Gray, N. J. Andrews, S. C. Clarke, A. M. Walker, M. R. Evans, J. S. Kroll, K. R. Neal, D. A. Ala'aldeen, D. W. Crook, K. Cann, S. Harrison, R. Cunningham, D. Baxter, E. Kaczmarski, J. Maclennan, J. C. Cameron, and J. M. Stuart. 2008. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197:737-743.
200. Maiden, M. C., and J. M. Stuart. 2002. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359:1829-1831.
201. Malbon, K., R. Mohan, and R. Nicholl. 2006. Should a neonate with possible late onset infection always have a lumbar puncture? Arch. Dis. Child. 91:75-76.
202. Marois, C., S. Bougeard, M. Gottschalk, and M. Kobisch. 2004. Multiplex PCR assay for detection of Streptococcus suis species and serotypes 2 and 1/2 in tonsils of live and dead pigs. J. Clin. Microbiol. 42:3169-3175.
203. Mattie, H., K. Stuertz, R. Nau, and J. T. van Dissel. 2005. Pharmacodynamics of antibiotics with respect to bacterial killing of and release of lipoteichoic acid by Streptococcus pneumoniae. J. Antimicrob. Chemother. 56:154-159.
204. Maxson, S., M. J. Lewno, and G. E. Schutze. 1994. Clinical usefulness of cerebrospinal fluid bacterial antigen studies. J. Pediatr. 125:235-238.
205. May, M., A. J. Daley, S. Donath, and D. Isaacs. 2005. Early onset neonatal meningitis in Australia and New Zealand, 1992-2002. Arch. Dis. Child. Fetal Neonatal Ed. 90:F324-F327.
206. McClelland, S., III, and W. A. Hall. 2007. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin. Infect. Dis. 45:55-59.
207. McIntyre, P. B., C. S. Berkey, S. M. King, U. B. Schaad, T. Kilpi, G. Y. Kanra, and C. M. Perez. 1997. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925-931.
208. McIntyre, P. B., C. R. Macintyre, R. Gilmour, and H. Wang. 2005. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch. Dis. Child. 90:391-396.
209. Mendsaikhan, J., J. P. Watt, O. Mansoor, N. Suvdmaa, K. Edmond, D. J. Litt, P. Nymadawa, Y. Baoping, D. Altantsetseg, and M. Slack. 2009. Childhood bacterial meningitis in Ulaanbaatar, Mongolia, 2002-2004. Clin. Infect. Dis. 48(Suppl. 2):S141-S146.
210. Miller, E., D. Salisbury, and M. Ramsay. 2001. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(Suppl. 1):S58-S67.
211. Mishal, J., A. Embon, A. Darawshe, M. Kidon, and E. Magen. 2008. Community acquired acute bacterial meningitis in children and adults: an 11-year survey in a community hospital in Israel. Eur. J. Intern. Med. 19:421-426.
212. Mitja, O., C. Pigrau, I. Ruiz, X. Vidal, B. Almirante, A. M. Planes, I. Molina, D. Rodriguez, and A. Pahissa. 2009. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J. Antimicrob. Chemother. 64:416-423.
213. Molyneux, E. M., M. Tembo, K. Kayira, L. Bwanaisa, J. Mweneychanya, A. Njobvu, H. Forsyth, S. Rogerson, A. L. Walsh, and M. E. Molyneux. 2003. The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. Arch. Dis. Child. 88:1112-1118.
214. Molyneux, E. M., A. L. Walsh, H. Forsyth, M. Tembo, J. Mwenechanya, K. Kayira, L. Bwanaisa, A. Njobvu, S. Rogerson, and G. Malenga. 2002. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 360:211-218.
215. Mook-Kanamori, B. B., M. S. Rouse, C. I. Kang, D. van de Beek, J. M. Steckelberg, and R. Patel. 2009. Daptomycin in experimental murine pneumococcal meningitis. BMC Infect. Dis. 9:50.
216. Moore, P. S. 1992. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin. Infect. Dis. 14:515-525.
217. Moore, P. S., M. W. Reeves, B. Schwartz, B. G. Gellin, and C. V. Broome. 1989. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet ii:260-263.
218. Morrissey, I., K. Maher, L. Williams, J. Shackcloth, D. Felmingham, and R. Reynolds. 2008. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007. J. Antimicrob. Chemother. 62(Suppl. 2):ii97-ii103.
219. Moszynski, P. 2009. Rwanda launches vaccination drive against pneumococcal disease in under 5s. BMJ 338:b1729.
220. Mourtzoukou, E. G., G. Pappas, G. Peppas, and M. E. Falagas. 2008. Vaccination of asplenic or hyposplenic adults. Br. J. Surg. 95:273-280.
221. Mudhune, S., and M. Wamae. 2009. Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumoniae from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin. Infect. Dis. 48(Suppl. 2):S147-S152.
222. Mulder, C. J., and H. C. Zanen. 1986. Listeria monocytogenes neonatal meningitis in the Netherlands. Eur. J. Pediatr. 145:60-62.
223. Muller, L. M., K. J. Gorter, E. Hak, W. L. Goudzwaard, F. G. Schellevis, A. I. Hoepelman, and G. E. Rutten. 2005. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin. Infect. Dis. 41:281-288.
224. Munoz-Almagro, C., I. Jordan, A. Gene, C. Latorre, J. J. Garcia-Garcia, and R. Pallares. 2008. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin. Infect. Dis. 46:174-182.
225. Musher, D. M. 1992. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 14:801-807.
226. Mylonakis, E., E. L. Hohmann, and S. B. Calderwood. 1998. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore) 77:313-336.
227. Nelson, S., and J. K. Kolls. 2002. Alcohol, host defence and society. Nat. Rev. Immunol. 2:205-209.
228. Nguyen, T. H., T. H. Tran, G. Thwaites, V. C. Ly, X. S. Dinh, T. N. H. Dang, Q. T. Dang, D. P. Nguyen, H. P. Nguyen, S. D. To, V. C. Nguyen, M. D. Nguyen, J. Campbell, C. Schultsz, C. Parry, M. E. Torok, N. White, T. C. Nguyen, T. H. Tran, K. Stepniewska, and J. J. Farrar. 2007. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N. Engl. J. Med. 357:2431-2440.
229. Ni, H., A. I. Knight, K. Cartwright, W. H. Palmer, and J. McFadden. 1992. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 340:1432-1434.
230. Nielsen, H. E., C. Koch, P. Magnussen, and I. Lind. 1989. Complement deficiencies in selected groups of patients with meningococcal disease. Scand. J. Infect. Dis. 21:389-396.
231. Nigrovic, L. E., N. Kuppermann, C. G. Macias, C. R. Cannavino, D. M. Moro-Sutherland, R. D. Schremmer, S. H. Schwab, D. Agrawal, K. M. Mansour, J. E. Bennett, Y. L. Katsogridakis, M. M. Mohseni, B. Bulloch, D. W. Steele, R. L. Kaplan, M. I. Herman, S. Bandyopadhyay, P. Dayan, U. T. Truong, V. J. Wang, B. K. Bonsu, J. L. Chapman, J. T. Kanegaye, and R. Malley. 2007. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA 297:52-60.
232. Nigrovic, L. E., N. Kuppermann, and R. Malley. 2002. Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era. Pediatrics 110:712-719.
233. Nigrovic, L. E., N. Kuppermann, and R. Malley. 2008. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad. Emerg. Med. 15:522-528.
234. Nigrovic, L. E., N. Kuppermann, A. J. McAdam, and R. Malley. 2004. Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis. Pediatr. Infect. Dis. J. 23:786-788.
235. Nigrovic, L. E., R. Malley, C. G. Macias, J. T. Kanegaye, D. M. Moro- Sutherland, R. D. Schremmer, S. H. Schwab, D. Agrawal, K. M. Mansour, J. E. Bennett, Y. L. Katsogridakis, M. M. Mohseni, B. Bulloch, D. W. Steele, R. L. Kaplan, M. I. Herman, S. Bandyopadhyay, P. Dayan, U. T. Truong, V. J. Wang, B. K. Bonsu, J. L. Chapman, and N. Kuppermann. 2008. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics 122:726-730.
236. Nkoumou, M. O., G. Betha, M. Kombila, and P. Clevenbergh. 2003. Bacterial and mycobacterial meningitis in HIV-positive compared with HIVnegative patients in an internal medicine ward in Libreville, Gabon. J. Acquir. Immune Defic. Syndr. 32:345-346.
237. Norgaard, M., G. Gudmundsdottir, C. S. Larsen, and H. C. Schonheyder. 2003. Staphylococcus aureus meningitis: experience with cefuroxime treatment during a 16 year period in a Danish region. Scand. J. Infect. Dis. 35:311-314.
238. Odio, C. M., I. Faingezicht, M. Paris, M. Nassar, A. Baltodano, J. Rogers, X. Saez-Llorens, K. D. Olsen, and G. H. McCracken, Jr. 1991. The bene- ficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 324:1525-1531.
239. Ohlsson, A., and T. L. Myhr. 1994. Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials. Am. J. Obstet. Gynecol. 170:910-917.
240. Omlin, A. G., K. Muhlemann, M. F. Fey, and T. Pabst. 2005. Pneumococcal vaccination in splenectomised cancer patients. Eur. J. Cancer 41:1731-1734.
241. Oppenheim, B. A. 1997. Antibiotic resistance in Neisseria meningitidis. Clin. Infect. Dis. 24(Suppl. 1):S98-S101.
242. Ostergaard, C., H. B. Konradsen, and S. Samuelsson. 2005. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect. Dis. 5:93.
243. Overturf, G. D. 2003. Indications for the immunological evaluation of patients with meningitis. Clin. Infect. Dis. 36:189-194.
244. Parent du Châtelet, I., Y. Traore, B. D. Gessner, A. Antignac, B. Naccro, B. M. Njanpop-Lafourcade, M. S. Ouedraogo, S. R. Tiendrebeogo, E. Varon, and M. K. Taha. 2005. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin. Infect. Dis. 40:17-25.
245. Paul, M. L., D. E. Dwyer, C. Chow, J. Robson, I. Chambers, G. Eagles, and V. Ackerman. 1994. Listeriosis-a review of eighty-four cases. Med. J. Aust. 160:489-493.
246. Pedersen, T. I., M. Howitz, and C. Ostergaard. Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post-vaccination era. Clin. Microbiol. Infect., in press.
247. Pedro, L. G., R. F. Boente, D. J. Madureira, J. A. Matos, C. M. Rebelo, R. P. Igreja, and D. E. Barroso. 2007. Diagnosis of meningococcal meningitis in Brazil by use of PCR. Scand. J. Infect. Dis. 39:28-32.
248. Pelkonen, T., I. Roine, L. Monteiro, M. Correia, A. Pitkaranta, L. Bernardino, and H. Peltola. 2009. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa. Clin. Infect. Dis. 48:1107-1110.
249. Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:302-317.
250. Peltola, H., I. Roine, J. Fernandez, I. Zavala, S. G. Ayala, A. G. Mata, A. Arbo, R. Bologna, G. Mino, J. Goyo, E. Lopez, S. D. de Andrade, and S. Sarna. 2007. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 45:1277-1286.
251. Perera, N., L. Abulhoul, M. R. Green, and R. A. Swann. 2005. Group A streptococcal meningitis: case report and review of the literature. J. Infect. 51:E1-E4.
252. Perez-Trallero, E., J. M. Marimon, M. Montes, B. Orden, and M. de Pablos. 1999. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg. Infect. Dis. 5:235-240.
253. Perkins, M. D., S. Mirrett, and L. B. Reller. 1995. Rapid bacterial antigen detection is not clinically useful. J. Clin. Microbiol. 33:1486-1491.
254. Phares, C. R., R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaffner, S. M. Zansky, K. Gershman, K. R. Stefonek, B. A. Albanese, E. R. Zell, A. Schuchat, and S. J. Schrag. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056-2065.
255. Pinner, R. W., B. G. Gellin, W. F. Bibb, C. N. Baker, R. Weaver, S. B. Hunter, S. H. Waterman, L. F. Mocca, C. E. Frasch, and C. V. Broome. 1991. Meningococcal disease in the United States - 1986. Meningococcal Disease Study Group. J. Infect. Dis. 164:368-374.
256. Pintado, V., M. A. Meseguer, J. Fortun, J. Cobo, E. Navas, C. Quereda, I. Corral, and S. Moreno. 2002. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 21:864-868.
257. Plotkin, S. A., and S. L. Kaplan. 2006. Meningococcal control in the United States and Africa. J. Infect. Dis. 193:754-755.
258. Pollard, A. J., G. Probe, C. Trombley, A. Castell, S. Whitehead, J. M. Bigham, S. Champagne, J. Isaac-Renton, R. Tan, M. Guiver, R. Borrow, D. P. Speert, and E. Thomas. 2002. Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Arch. Pathol. Lab. Med. 126:1209-1215.
259. Pong, A., and J. S. Bradley. 1999. Bacterial meningitis and the newborn infant. Infect. Dis. Clin. North Am. 13:711-733.
260. Ragunathan, L., M. Ramsay, R. Borrow, M. Guiver, S. Gray, and E. B. Kaczmarski. 2000. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report. J. Infect. 40:74-79.
261. Ramsay, M. E., N. Andrews, E. B. Kaczmarski, and E. Miller. 2001. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357:195-196.
262. Reichert, M. C., E. A. Medeiros, and F. A. Ferraz. 2002. Hospital-acquired meningitis in patients undergoing craniotomy: incidence, evolution, and risk factors. Am. J. Infect. Control 30:158-164.
263. Reynaud, L., M. Graf, I. Gentile, R. Cerini, R. Ciampi, S. Noce, F. Borrelli, C. Viola, F. Gentile, F. Briganti, and G. Borgia. 2007. A rare case of brainstem encephalitis by Listeria monocytogenes with isolated mesencephalic localization. Case report and review. Diagn. Microbiol. Infect. Dis. 58:121-123.
264. Rhomberg, P. R., and R. N. Jones. 2009. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagn. Microbiol. Infect. Dis. 65:414-426.
265. Ribeiro, G. S., J. N. Reis, S. M. Cordeiro, J. B. Lima, E. L. Gouveia, M. Petersen, K. Salgado, H. R. Silva, R. C. Zanella, S. C. Almeida, M. C. Brandileone, M. G. Reis, and A. I. Ko. 2003. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J. Infect. Dis. 187:109-116.
266. Robbins, J. B., R. Schneerson, P. Anderson, and D. H. Smith. 1996. The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines. JAMA 276:1181-1185.
267. Roca, A., Q. Bassat, L. Morais, S. Machevo, B. Sigauque, C. O'Callaghan, T. Nhamposa, E. Letang, I. Mandomando, D. Nhalungo, L. Quinto, and P. Alonso. 2009. Surveillance of acute bacterial meningitis among children admitted to a district hospital in rural Mozambique. Clin. Infect. Dis. 48(Suppl. 2):S172-S180.
268. Rosenstein, N. E., S. A. Stocker, T. Popovic, F. C. Tenover, and B. A. Perkins. 2000. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. Clin. Infect. Dis. 30:212-213.
269. Ross, S. C., and P. Densen. 1984. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63:243-273.
270. Saez-Llorens, X., and G. H. McCracken, Jr. 2003. Bacterial meningitis in children. Lancet 361:2139-2148.
271. Saez-Llorens, X., and G. H. McCracken, Jr. 2007. Glycerol and bacterial meningitis. Clin. Infect. Dis. 45:1287-1289.
272. Saez-Nieto, J. A., R. Lujan, S. Berron, J. Campos, M. Vinas, C. Fuste, J. A. Vazquez, Q. Y. Zhang, L. D. Bowler, and J. V. Martinez-Suarez. 1992. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin. Infect. Dis. 14:394-402.
273. Saha, S. K., A. Naheed, S. el-Arifeen, M. Islam, H. Al-Emran, R. Amin, K. Fatima, W. A. Brooks, R. F. Breiman, D. A. Sack, and S. P. Luby. 2009. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin. Infect. Dis. 48(Suppl. 2):S75-S81.
274. Scarborough, M., S. B. Gordon, C. J. Whitty, N. French, Y. Njalale, A. Chitani, T. E. Peto, D. G. Lalloo, and E. E. Zijlstra. 2007. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N. Engl. J. Med. 357:2441-2450.
275. Scarborough, M., and G. E. Thwaites. 2008. The diagnosis and management of acute bacterial meningitis in resource-poor settings. Lancet Neurol. 7:637-648.
276. Schlech, W. F., III, J. I. Ward, J. D. Band, A. Hightower, D. W. Fraser, and C. V. Broome. 1985. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA 253: 1749-1754.
277. Schlesinger, L. S., S. C. Ross, and D. R. Schaberg. 1987. Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 66:148-156.
278. Schrag, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm. Rep. 51(RR11):1-22.
279. Schrag, S. J., S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20.
280. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
281. Schuchat, A., and N. R. Messonnier. 2007. From pandemic suspect to the postvaccine era: the Haemophilus influenzae story. Clin. Infect. Dis. 44: 817-819.
282. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337:970-976.
283. Sekiya, Y., M. Eguchi, M. Nakamura, K. Ubukata, S. Omura, and H. Matsui. 2008. Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzae infection. BMC Infect. Dis. 8:15. doi:10.1186/1471-2334-8-15.
284. Shah, A. S., M. D. Knoll, P. R. Sharma, J. C. Moisi, P. Kulkarni, M. K. Lalitha, M. Steinhoff, and K. Thomas. 2009. Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance Network. Clin. Infect. Dis. 48(Suppl. 2): S123-S128.
285. Shameem, S., C. S. V. Kumar, and Y. F. Neelagund. 2008. Bacterial meningitis. Rapid diagnosis and microbial profile: a multicentered study. J. Commun. Dis. 40:111-120.
286. Siegman-Igra, Y., S. Bar-Yosef, A. Gorea, and J. Avram. 1993. Nosocomial Acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin. Infect. Dis. 17:843-849.
287. Sigurdardottir, B., O. M. Bjornsson, K. E. Jonsdottir, H. Erlendsdottir, and S. Gudmundsson. 1997. Acute bacterial meningitis in adults. A 20-year overview. Arch. Intern. Med. 157:425-430.
288. Sjoholm, A. G., E. J. Kuijper, C. C. Tijssen, A. Jansz, P. Bol, L. Spanjaard, and H. C. Zanen. 1988. Dysfunctional properdin in a Dutch family with meningococcal disease. N. Engl. J. Med. 319:33-37.
289. Snape, M. D., K. P. Perrett, K. J. Ford, T. M. John, D. Pace, L. M. Yu, J. M. Langley, S. McNeil, P. M. Dull, F. Ceddia, A. Anemona, S. A. Halperin, S. Dobson, and A. J. Pollard. 2008. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA 299:173-184.
290. Snape, M. D., and A. J. Pollard. 2005. Meningococcal polysaccharide- protein conjugate vaccines. Lancet Infect. Dis. 5:21-30.
291. Sormunen, P., M. J. Kallio, T. Kilpi, and H. Peltola. 1999. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J. Pediatr. 134:725-729. (Pubitemid 30186816)
292. Spagnuolo, P. J., J. J. Ellner, P. I. Lerner, M. C. McHenry, F. Flatauer, P. Rosenberg, and M. S. Rosenthal. 1982. Haemophilus influenzae meningitis: the spectrum of disease in adults. Medicine (Baltimore) 61:74-85. (Pubitemid 12158544)
293. Spanos, A., F. E. Harrell, Jr., and D. T. Durack. 1989. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 262:2700-2707.
294. Spreer, A., R. Lugert, V. Stoltefaut, A. Hoecht, H. Eiffert, and R. Nau. 2009. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit. Care Med. 37: 2253-2258.
295. Stanek, R. J., and M. A. Mufson. 1999. A 20-year epidemiological study of pneumococcal meningitis. Clin. Infect. Dis. 28:1265-1272.
296. Steinhoff, M., and D. Goldblatt. 2003. Conjugate Hib vaccines. Lancet 361:360-361.
297. Stephens, D. S., B. Greenwood, and P. Brandtzaeg. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196-2210.
298. Swartz, M. N., and P. R. Dodge. 1965. Bacterial meningitis - a review of selected aspects. 1. General clinical features, special problems and unsual meningeal reactions mimicking bacterial meningitis. N. Engl. J. Med. 272: 842-848.
299. Takala, A. K., J. Eskola, and L. van Alphen. 1990. Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch. Intern. Med. 150: 2573-2576.
300. Tang, L. M., and S. T. Chen. 1994. Klebsiella ozaenae meningitis: report of two cases and review of the literature. Infection 22:58-61.
301. Tang, L. M., and S. T. Chen. 1995. Klebsiella oxytoca meningitis: frequent association with neurosurgical procedures. Infection 23:163-167.
302. Tarafdar, K., S. Rao, R. A. Recco, and M. M. Zaman. 2001. Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis. Clin. Infect. Dis. 33:406-408.
303. Tauber, M. G., S. L. Kennedy, J. H. Tureen, and D. H. Lowenstein. 1992. Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. Am. J. Pathol. 141:53-60.
304. Tebruegge, M., and N. Curtis. 2008. Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin. Microbiol. Rev. 21: 519-537.
305. Theodoridou, M. N., V. A. Vasilopoulou, E. E. Atsali, A. M. Pangalis, G.
306. Thigpen, M. C., N. E. Rosenstein, C. G. Whitney, R. Lynfield, M. M. Farley, A. S. Craig, J. Hadler, L. H. Harrison, K. Gershman, N. M. Bennett, A. R. Thomas, A. Reingold, and A. Schuchat. 2005. Bacterial meningitis in the United States - 1998-2003, abstr. 1171. Abstr. 43rd Annu. Meet. Infect. Dis. Soc. Am., San Francisco, CA.
307. Tran, T. T., Q. T. Le, T. N. Tran, N. T. Nguyen, F. K. Pedersen, and M. Schlumberger. 1998. The etiology of bacterial pneumonia and meningitis in Vietnam. Pediatr. Infect. Dis. J. 17:S192-S194.
308. Traore, Y., T. A. Tameklo, B. M. Njanpop-Lafourcade, M. Lourd, S. Yaro, D. Niamba, A. Drabo, J. E. Mueller, J. L. Koeck, and B. D. Gessner. 2009. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo. Clin. Infect. Dis. 48 (Suppl. 2):S181-S189.
309. Tsai, C. J., M. R. Griffin, J. P. Nuorti, and C. G. Grijalva. 2008. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin. Infect. Dis. 46:1664-1672.
310. Tully, J., R. M. Viner, P. G. Coen, J. M. Stuart, M. Zambon, C. Peckham, C. Booth, N. Klein, E. Kaczmarski, and R. Booy. 2006. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ 332:445-450.
311. Tunkel, A. R. 2001. Bacterial meningitis. Lippincott Williams & Wilkins, Philadelphia, PA.
312. Tunkel, A. R., B. J. Hartman, S. L. Kaplan, B. A. Kaufman, K. L. Roos, W. M. Scheld, and R. J. Whitley. 2004. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39:1267-1284.
313. Tzanakaki, G., M. Tsopanomichalou, K. Kesanopoulos, R. Matzourani, M. Sioumala, A. Tabaki, and J. Kremastinou. 2005. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae. Clin. Microbiol. Infect. 11: 386-390.
314. Unhanand, M., M. M. Mustafa, G. H. McCracken, Jr., and J. D. Nelson. 1993. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J. Pediatr. 122:15-21.
315. Urwin, G., M. F. Yuan, and R. A. Feldman. 1994. Prospective study of bacterial meningitis in North East Thames region, 1991-3, during introduction of Haemophilus influenzae vaccine. BMJ 309:1412-1414. (Pubitemid 24351410)
316. van Alphen, L., L. Spanjaard, H. D. van der Lei, I. Schuurman, and J. Dankert. 1997. Effect of nationwide vaccination of 3-month-old infants in the Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. J. Pediatr. 131:869-873.
317. van de Beek, D., J. de Gans, P. McIntyre, and K. Prasad. 2004. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect. Dis. 4:139-143.
318. van de Beek, D., J. de Gans, P. McIntyre, and K. Prasad. 2007. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. 2007: CD004405.
319. van de Beek, D., J. de Gans, L. Spanjaard, S. Sela, M. Vermeulen, and J. Dankert. 2002. Group A streptococcal meningitis in adults: report of 41 cases and a review of the literature. Clin. Infect. Dis. 34:e32-e36.
320. van de Beek, D., J. de Gans, L. Spanjaard, M. Weisfelt, J. B. Reitsma, and M. Vermeulen. 2004. Clinical features and prognostic factors in adults with bacterial meningitis. N. Engl. J. Med. 351:1849-1859.
321. van de Beek, D., J. de Gans, A. R. Tunkel, and E. F. Wijdicks. 2006. Community-acquired bacterial meningitis in adults. N. Engl. J. Med. 354: 44-53.
322. van de Beek, D., J. M. Drake, and A. R. Tunkel. 2010. Nosocomial bacterial meningitis. N. Engl. J. Med. 362:146-154.
323. van de Beek, D., B. Schmand, J. de Gans, M. Weisfelt, H. Vaessen, J. Dankert, and M. Vermeulen. 2002. Cognitive impairment in adults with good recovery after bacterial meningitis. J. Infect. Dis. 186:1047-1052.
324. van de Beek, D., L. Spanjaard, and J. de Gans. 2008. Streptococcus suis meningitis in the Netherlands. J. Infect. 57:158-161.
325. van de Beek, D., M. Weisfelt, J. de Gans, A. R. Tunkel, and E. F. Wijdicks. 2006. Drug insight: adjunctive therapies in adults with bacterial meningitis. Nat. Clin. Pract. Neurol. 2:504-516.
326. van Deuren, M., B. J. van Dijke, R. J. Koopman, A. M. Horrevorts, J. F. Meis, F. W. Santman, and J. W. van der Meer. 1993. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306:1229-1232.
327. van Driel, J. J., V. Bekker, L. Spanjaard, A. van der Ende, and T. W. Kuijpers. 2008. Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988-2005. Clin. Infect. Dis. 47:e42-e51.
328. Vilaichone, R. K., W. Vilaichone, P. Nunthapisud, and H. Wilde. 2002. Streptococcus suis infection in Thailand. J. Med. Assoc. Thai. 85(Suppl. 1):S109-S117.
329. Vincent, J. L., S. Nadel, D. J. Kutsogiannis, R. T. Gibney, S. B. Yan, V. L. Wyss, J. E. Bailey, C. L. Mitchell, S. Sarwat, S. M. Shinall, and J. M. Janes. 2005. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit. Care 9:R331-R343.
330. Vinchon, M., and P. Dhellemmes. 2006. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv. Syst. 22:692-697.
331. Voetsch, A. C., F. J. Angulo, T. F. Jones, M. R. Moore, C. Nadon, P. McCarthy, B. Shiferaw, M. B. Megginson, S. Hurd, B. J. Anderson, A. Cronquist, D. J. Vugia, C. Medus, S. Segler, L. M. Graves, R. M. Hoekstra, and P. M. Griffin. 2007. Reduction in the incidence of invasive listeriosis in foodborne diseases active surveillance network sites, 1996-2003. Clin. Infect. Dis. 44:513-520.
332. Vu, D. M., J. A. Welsch, P. Zuno-Mitchell, J. V. la Cruz, and D. M. Granoff. 2006. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. J. Infect. Dis. 193:821-828.
333. Wald, E. R., I. Bergman, H. G. Taylor, D. Chiponis, C. Porter, and K. Kubek. 1986. Long-term outcome of group B streptococcal meningitis. Pediatrics 77:217-221. (Pubitemid 16212873)
334. Wald, E. R., S. L. Kaplan, E. O. Mason, Jr., D. Sabo, L. Ross, M. Arditi, B. L. Wiedermann, W. Barson, K. S. Kim, and R. Yogov. 1995. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics 95:21-28.
335. Weightman, N. C., and J. Sajith. 2005. Incidence and outcome of pneumococcal meningitis in northern England. Eur. J. Clin. Microbiol. Infect. Dis. 24:542-544.
336. Weisfelt, M., J. de Gans, and D. van de Beek. 2007. Bacterial meningitis: a review of effective pharmacotherapy. Expert Opin. Pharmacother. 8:1493-1504.
337. Weisfelt, M., J. de Gans, T. van der Poll, and D. van de Beek. 2006. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 5:332-342.
338. Weisfelt, M., D. van de Beek, L. Spanjaard, and J. de Gans. 2006. Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect. Dis. 6:64.
339. Weisfelt, M., D. van de Beek, L. Spanjaard, and J. de Gans. 2007. Nosocomial bacterial meningitis in adults: a prospective series of 50 cases. J. Hosp. Infect. 66:71-78.
340. Weisfelt, M., D. van de Beek, L. Spanjaard, J. B. Reitsma, and J. de Gans. 2006. Attenuated cerebrospinal fluid leukocyte count and sepsis in adults with pneumococcal meningitis: a prospective cohort study. BMC Infect. Dis. 6:149.
341. Weisfelt, M., D. van de Beek, L. Spanjaard, J. B. Reitsma, and J. de Gans. 2006. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 5:123-129.
342. Weisfelt, M., D. van de Beek, L. Spanjaard, J. B. Reitsma, and J. de Gans. 2006. Community-acquired bacterial meningitis in older people. J. Am. Geriatr. Soc. 54:1500-1507.
343. Weiss, D. P., P. Coplan, and H. Guess. 2001. Epidemiology of bacterial meningitis among children in Brazil, 1997-1998. Rev. Saude Publica 35: 249-255. (In Portugese.)
344. Welinder-Olsson, C., L. Dotevall, H. Hogevik, R. Jungnelius, B. Trollfors, M. Wahl, and P. Larsson. 2007. Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitis. Clin. Microbiol. Infect. 13:879-886.
345. Wenger, J. D., A. W. Hightower, R. R. Facklam, S. Gaventa, and C. V. Broome. 1990. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J. Infect. Dis. 162:1316-1323.
346. Werno, A. M., and D. R. Murdoch. 2008. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin. Infect. Dis. 46:926-932.
347. Wertheim, H. F., H. D. Nghia, W. Taylor, and C. Schultsz. 2009. Streptococcus suis: an emerging human pathogen. Clin. Infect. Dis. 48:617-625.
348. Wertheim, H. F., H. N. Nguyen, W. Taylor, T. T. Lien, H. T. Ngo, T. Q. Nguyen, B. N. Nguyen, H. H. Nguyen, H. M. Nguyen, C. T. Nguyen, T. T. Dao, T. V. Nguyen, A. Fox, J. Farrar, C. Schultsz, H. D. Nguyen, K. V. Nguyen, and P. Horby. 2009. Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam. PLoS One 4:e5973.
349. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.
350. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, C. Lexau, A. Reingold, L. Lefkowitz, P. R. Cieslak, M. Cetron, E. R. Zell, J. H. Jorgensen, and A. Schuchat. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:1917-1924.
351. Wilder-Smith, A., K. T. Goh, T. Barkham, and N. I. Paton. 2003. Hajjassociated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin. Infect. Dis. 36:679-683.
352. Williams, E. J., S. Thorson, M. Maskey, S. Mahat, M. Hamaluba, S. Dongol, A. M. Werno, B. K. Yadav, A. S. Shah, D. F. Kelly, N. Adhikari, A. J. Pollard, and D. R. Murdoch. 2009. Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal. Clin. Infect. Dis. 48(Suppl. 2):S114-S122.
353. Wolf, R. E., and C. A. Birbara. 1968. Meningococcal infections at an army training center. Am. J. Med. 44:243-255.
354. Yu, H., H. Jing, Z. Chen, H. Zheng, X. Zhu, H. Wang, S. Wang, L. Liu, R. Zu, L. Luo, N. Xiang, H. Liu, X. Liu, Y. Shu, S. S. Lee, S. K. Chuang, Y. Wang, J. Xu, and W. Yang. 2006. Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 12:914-920.
355. Zaidi, A. K., H. Khan, R. Lasi, and W. Mahesar. 2009. Surveillance of pneumococcal meningitis among children in Sindh, southern Pakistan. Clin. Infect. Dis. 48(Suppl. 2):S129-S135.
356. Zoons, E., M. Weisfelt, J. de Gans, L. Spanjaard, J. H. Koelman, J. B. Reitsma, and D. van de Beek. 2008. Seizures in adults with bacterial meningitis. Neurology 70:2109-2115.
357. Zoppi, M., M. Weiss, U. E. Nydegger, T. Hess, and P. J. Spath. 1990. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe. Arch. Intern. Med. 150:2395-2399.